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Smoke chemistryMainstream smoke (MS) from experimental kretek cigarettes with three ingredient mixes at low (typical
use level) and high (2.5 or 3 times that level) inclusion rates was compared to a control kretek cigarette of
identical construction (cloves and humectants), but without the addition of ingredients. 350 ingredients,
commonly used in various combinations and in a limited number in a given brand in the manufacture of
marketed kretek cigarettes were assessed. The MS composition of the kretek cigarettes was characterized
by a comprehensive set of analytes (55 smoke constituents). Furthermore, the smoke was assessed
in vitro for its cytotoxicity in the Neutral Red Uptake assay (particle phase and gas/vapor phase sepa-
rately) in mouse embryo BALB/c 3T3 cells, and for mutagenicity/genotoxicity in the Salmonella typhimu-
rium reverse mutation assay and the mammalian cell mouse lymphoma TK assay in L5178Y cells, the
latter with and without metabolic activation. There were some statistically signiﬁcant differences in
the yield of smoke constituents (increases as well as decreases, nearly all of them less than ±20%) as a
result of the addition of the ingredient mixes. However, the addition of the three different mixes of ingre-
dients to the experimental kreteks did not change the in vitro cytotoxicity and mutagenicity/genotoxicity
of the smoke, when compared to the control kretek cigarette.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction
This publication is part of a series summarizing the in vitro and
in vivo toxicological assessment of kretek cigarettes. Smoke com-
position and biological activity of mainstream smoke (MS) from
marketed and experimental kretek cigarettes were evaluated on
a comparative basis in smoke chemistry analyses, and in vitro
and in vivo toxicity studies. The studies were designed to cover
three main topics: (1) characterization of kreteks and comparison
relative to American-blended cigarettes, (2) impact of blend type
and cloves, and (3) impact of ingredients used in kretek cigarettes.
Further in depth information of this assessment is described in the
lead publication (Roemer, 2014b).
Kretek cigarettes contain clove buds in addition to tobacco in
the ﬁller (up to 40%) that gives them their unique taste and smell.
In addition to the clove buds they also contain ﬂavor ingredientsaccording to the smoking preferences of the different consumer
groups. Other ingredients are used to facilitate tobacco processing
and to preserve tobacco moisture (LaVoie et al., 1986). Historically,
many tobacco farmers applied a substance mixture of undisclosed,
secret composition, the sauce, already to the tobacco before deliv-
ery to the cigarette manufacturers (Polzin et al., 2007). The sauce
consisted mainly of ﬂavors and substances that release ﬂavors
upon combustion. Today, at least for the main kretek cigarette
manufacturers, the sauce has been replaced by the addition of a
mix of deﬁned ﬂavoring and moistening substances to the tobacco
in the factory with full disclosure of the single ingredients by the
vendors to allow a review whether a single ingredient might
increase the inherent toxicity of the smoke at the level used.
More than 400 of the ingredients used in various combinations
in American-blended cigarettes have been tested for their effects
on smoke chemistry and toxicological activity (Gaworski et al.,
1999; Heck et al., 2002; Roemer et al., 2002; Rustemeier et al.,
2002; Vanscheeuwijck et al., 2002; Baker and Bishop, 2004;
Baker et al., 2004a,b; Roemer et al., 2004; Renne et al., 2006;




Control Mix A low Mix A high Mix B low Mix B high Mix C low Mix C high
Cigarette weight (g) 1.44 1.41 1.42 1.43 1.43 1.46 1.40
Blend weight (g) 1.22 1.19 1.20 1.21 1.21 1.24 1.18
Clove weight (g) 0.38 0.37 0.37 0.38 0.38 0.38 0.37
Eugenol (mg) 3.64 4.21 3.88 4.60 4.40 3.56 3.49
Humectants weight (mg) 21.00 20.50 20.60 20.80 20.80 21.30 20.30
Ingredients weight (mg) 0.00 142.00 383.00 145.00 413.00 149.00 425.00
Cigarette length (mm) 89.90 89.90 90.00 89.80 90.10 90.20 90.10
Circumference (mm) 24.80 24.80 24.80 24.90 24.80 24.80 24.80
Paper porosity (C.U.) 57.80 57.40 58.90 57.40 57.20 56.60 57.30
Remarks: blend is comprising tobacco and cloves, eugenol refers to content in tobacco.
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ever, as the combination of cloves and ingredients may lead to
effects which are not observable in American-blended cigarettes,
these ingredients together with those used exclusively in kretek
cigarettes were investigated. The ingredients were incorporated
into the tobacco blend in three different mixes (termed Mix A, B,
and C).
Comprehensive analyses were made of smoke chemistry, with a
target of 55 smoke constituents. This list of analytes is based on
recommendations from two groups of public health experts: the
International Agency on Cancer Research and the US Consumer
Product Safety Commission (IARC, 1985, US-CPSC, 1993). Nearly
identical lists have been applied at other laboratories investigating
cigarette smoke (Bombick et al., 1998; Gaworski et al., 1999; Chen
and Moldoveanu, 2003; Stavanja et al., 2006; Potts et al., 2010).
Cigarettes were also tested for their in vitro cytotoxicity using
the Neutral Red Uptake (NRU) assay described by Borenfreund
and Puerner (1985). Two mutagenicity/genotoxicity assays were
included as they were recommended in the guidelines of the Inter-
national Conference on Harmonization developed for pharmaceuti-
cals (US-DHHS, 2008). These assays were the conventional and
widely used Salmonella Reverse Mutation Assay in 5 bacterial
strains developed by Ames et al. (1973) and the Mouse Lymphoma
Assay (MLA) using L5178Y cells (Clive et al., 1972). It has been
shown previously that this mammalian cell genotoxicity assay
can be reliably used to assess and compare the mutagenicity of
TPM (Schramke et al., 2006). At least the NRU assay and the Ames
Assay have become a quasi-standard in cigarette smoke toxicology
(Baker et al., 2004a; Stavanja et al., 2006; Potts et al., 2010;
Dempsey et al., 2011; Gaworski et al., 2011; Roemer et al., 2012).
Part 7 of this series of publications, reports on the results of the
inhalation toxicity of mainstream smoke of the kretek cigarettes
with the addition of the ingredient mixes A, B, and C (Schramke
et al., 2014).2. Materials and methods
2.1. General
Detailed descriptions regarding the chemical analyses, toxico-
logical assays and statistical procedures can be found in the ﬁrst
of this series of publications (Roemer et al., 2014b).
For logistic reasons the NRU assay and the MLA were performed
with kretek ingredient Mixes A and B in separate experiments to
Mix C.
2.2. Cigarettes
A total of 350 ingredients, commonly used in various combina-
tions and in a limited number in a given brand in the manufactureof marketed kretek cigarettes, were assigned to three different
ingredient mixes, i.e., Mix A, Mix B, and Mix C (see Appendix,
Table A). The ingredients were introduced in the respective mix
at a low and a high target level. The addition levels to these test
cigarettes were the typical use level and either 2.5 (licorice extract
and invert sugar) or three times the use level. The mixes were
added to experimental cigarettes containing, beside the Indonesian
tobacco, 31% cut cloves and 1.7% humectants (propylene glycol,
glycerin, and D-sorbitol) as ﬁller, similar to the Kretek-R reported
earlier (Piadé et al., 2014). Further details on the cigarettes can
be found in Table 1. As the cigarettes were manufactured to a con-
stant weight, the ingredients partly replaced the ﬁller. They were
added to the ﬁller at that point in the cigarette production process
(casing and after-cut) where they are normally added in the indus-
trial fabrication process, some ingredients were therefore added to
more than one mix. There were differences in target/addition con-
centrations of the individual ingredients concentrations in tobacco
and those after the manufacturing process. These differences were
considered to represent normal manufacturing losses due to evap-
oration or chemical interaction with tobacco components.
The list of tested ingredients, their regulatory status and the tar-
get concentrations in each mix is given in the Appendix in Table A.
Each ingredient was of food grade quality. A cigarette of identical
construction (cloves and humectants) but without the addition of
ingredients, served as control cigarette. Control and test cigarettes
were produced by PT Hanjaya Mandala Sampoerna Tbk., Surabaya,
Indonesia. The American-blended reference cigarette 2R4F was
used as internal reference cigarette. The reference cigarette 2R4F
was purchased from the University of Kentucky, Kentucky Tobacco
Research and Development Center (Davis and Vaught, 1990).
2.3. Smoke generation
The control and test cigarettes were conditioned for at least 48 h
under a fume hood in their original, sealed packs at 22 ± 2 C and
relative humidity of 60 ± 5%. They were then unpacked and trans-
ferred in sealed storage boxes for transportation to the smoking
machine. The 2R4F cigarettes were conditioned according to ISO
standard 3402 (ISO, 1999).The cigarettes were smoked on a 20-port
Borgwaldt smoking machine RM20H under ISO smoking conditions
(ISO, 1991a). In short, puff volume, puff duration, and puff frequency
for the ISO smoking conditions were 35 ml, 2 s, and 1/min.
Cigarettes were smoked to a ﬁnal butt length of 35 mm.
2.4. Smoke chemistry
In addition to the ISO analytes, TPM, nicotine, carbon monoxide
(CO), and water (ISO, 1991b, 2000, 2007), further analytes were
selected based on two source documents: a proposal that speciﬁ-
cally focused on smoke chemistry testing from the US Consumer
Fig. 1. Smoke chemistry, cigarettes with inclusion of Mix A at a low and high level relative to control cigarette (%), on a per mg TPM basis. Remarks: =, difference statistically
not signiﬁcant; ⁄, statistically different; ﬁrst symbol represents comparison of Mix at low level to control; second symbol comparison of Mix at high level to control.
Fig. 2. Smoke chemistry, cigarettes with inclusion of Mix B at a low and high level relative to control cigarette (%), on a per mg TPM basis. Remarks: =, difference statistically
not signiﬁcant; ⁄, statistically different; ﬁrst symbol represents comparison of Mix at low level to control; second symbol comparison of Mix at high level to control.
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from the International Agency for Research on Cancer (IARC,
1985). Analytes were quantiﬁed according to established method-
ology as previously described (Roemer et al., 2004).
2.5. In vitro cytotoxicity
Cytotoxicity of TPM and the water soluble constituents of the
gas/vapor phase (GVP) of MS was assessed with the Neutral RedUptake (NRU) assay (Borenfreund and Puerner, 1985, 1987) with
mouse embryo BALB/c 3T3 cells as previously described (Roemer
et al., 2009).2.6. In vitro bacterial mutagenicity
Mutagenicity of TPM was assessed in the plate incorporation
Salmonella Reverse Mutation Assay (Maron and Ames, 1983)
Fig. 3. Smoke chemistry, cigarettes with inclusion of Mix C at a low and high level relative to control cigarette (%), on a per mg TPM basis. Remarks: =, difference statistically
not signiﬁcant; ⁄, statistically different; ﬁrst symbol represents comparison of Mix at low level to control; second symbol comparison of Mix at high level to control.
Fig. 4. In vitro cytotoxicity on a per mg TPM basis of American-blended reference
cigarette 2R4F and experimental cigarettes containing no (control) or inclusions of
kretek ingredient mixes A, B, and C. Data are expressed as mean (n = 3) of the 1/EC50
values.
Fig. 5. In vitro bacterial mutagenicity on a per mg TPM basis of American-blended
reference cigarette 2R4F and experimental cigarettes containing no (control) or
inclusions of kretek ingredient mixes A, B, and C. Mutagenicity results are expressed
as mean (n = 2, with 3 plates per batch) of the revertants/mg TPM values.
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previously described (Roemer et al., 2012).
Determinations were performed in the presence and in the
absence of a metabolic activation system.2.7. In vitro mammalian cell genotoxicity
Genotoxicity of TPM was assessed in the Mouse Lymphoma TK
Assay (MLA) developed by Clive et al. (1972). It was performed
according to OECD guideline 476 (OECD, 1997b) in the microtiter
plate version (Cole et al., 1986) with L5178Y cells with and without
metabolic activation as described in detail by Schramke et al.
(2006).2.8. Statistics
Results obtained for the test cigarette groups were compared to
the control cigarette group with standard statistical tools. The ref-
erence cigarette 2R4F was only used as an internal reference to
monitor consistency with historical data of the laboratory and
was not included in the statistical evaluation.3. Results
3.1. Smoke chemistry
The following smoke constituents were below the limit of quan-
titation (LOQ) in smoke from control and/or test kretek cigarettes,
and consequently they will not be discussed further: N-nitroso-
dimethylamine (NDMA), N-nitrosomethylethylamine (NMEA), N-
nitrosodiethylamine (NDEA), N-nitrosodi-n-propylamine(NPRA),
Fig. 6. In vitro genotoxicity in mouse lymphoma cells on a per mg TPM basis of
American-blended reference cigarette 2R4F and experimental cigarettes containing
no (control) or inclusions of kretek ingredient mixes A, B, and C. Mutagenicity
results are given as 1/C3B values calculated over the two TPM batches tested.
Remarks: 2R4F a and Control a refers to Mix A and B, 2R4F b and Control b refers to
Mix C as groups tested parallel.
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nitrosopiperidine (NPI), dibenz[a,h]anthracene, dibenz[a,h]pyrene,
dibenz[a,i]pyrene, dibenzo[a,l]pyrene, 5-methylchrysene, nickel,
arsenic, and chromium.
Results on a per cigarette basis are presented in the in the
Appendix in Table B. Results expressed on a per mg total particu-
late matter (TPM) basis relative to the control cigarette are
presented in Figs. 1–3. There were a few sporadic signiﬁcant differ-
ences between control and test cigarettes, but nearly all of them
were smaller than ±20% and there was generally no relationship
between smoke constituent yield and added ingredient levels. As
the TPM deliveries of the test and control cigarettes were similar,
the small differences between the cigarettes remain the same as
on a per cigarette basis when expressed in percentage terms.3.2. In vitro cytotoxicity
Acrolein as positive control substance (data not shown) as well
as TPM and GVP of the reference cigarette 2R4F produced cytotox-
icity results consistent with historical data from the laboratory.
Cytotoxicity results on a per cigarette basis are given in the
Appendix in Table C. There were no signiﬁcant differences between
the mean 1/EC50 values for Mixes A, B and C, compared with the
appropriate control cigarette data, for both the TPM and the GVP.
When compared on a per mg TPM basis, according to the nearly
identical TPM yield of the cigarettes, there were also no signiﬁcant
differences between control and test cigarettes for both the TPM
and GVP fractions (Fig. 4). Cytotoxicity of TPM from the reference
cigarette 2R4F was approximately the same as that from the exper-
imental cigarettes (control and test), but the cytotoxicity of the
GVP was approximately twice as high.3.3. In vitro bacterial mutagenicity
Strain- and S9-speciﬁc positive control substances (data not
shown) as well as TPM of the reference cigarette 2R4F produced
mutagenicity results consistent with historical data from the
laboratory.
The tester strains TA102 and TA1535, with and without S9,
were unresponsive to the treatment with TPM and are not
discussed further.Mutagenicity results of TPM from the control and test cigarettes
on a per cigarette basis are given in the Appendix in Table C. There
were no signiﬁcant differences between the mutagenicity of TPM
from the test cigarettes containing either Mix A, B or C when com-
pared to that of the control cigarette.
On a per mg TPM basis, mutagenicity results for TPM of the test
cigarettes containing Mix A, B or C were very similar to those of the
control cigarette, for both low and high inclusions. There were no
cases of signiﬁcant differences from the control cigarette. The most
responsive strain for all cigarettes tested was TA98 with S9
(approximately 1100 revertants per mg TPM for the experimental
cigarettes, and 3000 revertants per mg TPM for the reference ciga-
rette 2R4F); the least responsive strain with discriminative ability
was TA100 without S9 (around 70 revertants per mg TPM for each
cigarette type). See Fig. 5 for the mutagenicity results observed in
the tester strains TA98 and TA100 with S9, and TA100 without S9
for the TPM of the tested cigarettes.3.4. In vitro mammalian cell genotoxicity
Methyl methanesulfonate and benzo[a]pyrene as positive con-
trol substances (data not shown) as well as the TPM of the refer-
ence cigarette 2R4F produced mutagenicity results consistent
with historical data from the laboratory.
Genotoxicity results on a per cigarette basis are given in the
Appendix in Table C. There were no signiﬁcant differences between
the genotoxicity of TPM from the test cigarettes containing either
Mix A, B or C when compared to that of the control cigarette.
On a per mg TPM basis, results for TPM of the test cigarettes
containing Mix A, B or C were very similar to those of the control
cigarette, for both low and high inclusions as well as with and
without metabolic activation. There were no cases of signiﬁcant
differences from the control cigarette. Without metabolic activa-
tion, mutagenicity data for the reference cigarette 2R4F were
approximately the same as for the experimental cigarettes. Values
with S9 were approximately two times lower for the reference cig-
arette 2R4F (Fig. 6).4. Discussion
In this study three mixes of ingredients typically used in the
manufacture of kretek cigarettes were tested. Addition of ingredi-
ents to kretek cigarettes at levels up to 3-fold of their use level
did not discernibly alter the smoke chemistry proﬁle of the selected
major toxic constituents of smoke. The lack of differences in smoke
composition of the experimental cigarettes with and without ingre-
dients is mirrored by a lack of differences in the in vitro toxicity.
This result conﬁrms the ﬁndings observed in a study on ingre-
dients used in American-blended cigarettes (Carmines, 2002), as
approximately 260 of the ingredients tested here had been tested
there without any evidence that the addition of ingredients to
the tobacco might increase the inherent toxicity of cigarette
smoke.
There is an increasing trend to report cigarette emission data
per mg nicotine, as, e.g., suggested by authorative bodys, e.g.,
World Health Organization (WHO, 2009), but also by individual
researchers (Rickert et al., 2007, 2011; Ashley et al., 2008). This
might be useful, e.g., when comparing different brand available
on the market. However, in the conduct of the toxicological assess-
ment of ingredient, this may be misleading (DIN, 2014). Often, the
experimental cigarettes, used in this context, contain a rather high
concentration (normally not found in market cigarettes) of ingredi-
ents that do not emit any nicotine into the smoke. Thus, a normal-
ization to nicotine would lead to higher emission data for the test
cigarettes with the addition of ingredients compared to control
E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S66–S80 S71cigarette without ingredients. In our studies, reported here, the test
cigarettes did not differ more than 6% compared to the control. As
such, a normalization to nicotine has no considerable inﬂuence on
the comparisons and conclusions, compared to our normalization
to TPM.
The authors have chosen the ISO smoking regimen in this study
for two reasons. First, it has been shown that more intense smok-
ing regimens, e.g., required by Health Canada (1999), are less efﬁ-
cient in detecting possible differences in the yield of toxicants
when comparing different cigarette types Carchman (Roemer and
Carchman, 2011). Second, more intense smoking regimens than
the ISO obviously overestimate the smoke uptake by human smok-
ers of cigarettes with higher tar yields, e.g., around 10 mg ISO tar.
For kretek cigarettes with a yield of up to 50 mg ISO tar the appli-
cation of intense smoking regimens would lead to estimated tar
yields of far more than 100 mg per cigarette. These values have
obviously no relationship to the actual intake of a smoker.
Although not within the scope of the studies presented here, it
might be interesting to compare the in vitro response of the Amer-
ican-blended reference cigarette 2R4F with that of the experimen-
tal kreteks. As the particulate phase showed the same cytotoxicity,
the GVP of the experimental kretek cigarette smoke is distinctly
lower in activity. Also the mutagenic activity of the particulate
phase of the kretek smoke is only approximately one half and less
in the most responsive Salmonella tester strains. This conﬁrms the
data obtained in other in vitro experiments within this set of stud-
ies (Piadé et al., 2014). In the mouse lymphoma assay, however, the
mutagenic activity of TPM from the experimental kreteks in the
presence of metabolic activation, was double that of the reference
cigarette 2R4F. This is in agreement with the response toward pure
eugenol obtained in this series of studies (Roemer et al., 2014a) or
observed by other researchers (Tennant et al., 1987; Myhr and
Caspary, 1991). It is possible that this is a false positive, as this
assay is known for a rather high rate of false positives (Lorge
et al., 2007; Reeve et al., 2012). In other in vitro and in vivoTable A
Listing of ingredients tested.





1,8-Cineole 470-82-6 2465 182 12
1-Octen-3-ol 3391-86-4 2805 72 11
1-Pentanol 71-41-0 2056 514 88
2-Methylpyrazine 109-08-0 3309 2270 76
2,3,5,6-Tetramethylpyrazine 1124-11-4 3237 2210 78
2,3,5-Trimethylpyrazine 14667-55-1 3244 735 77
2,3-Diethylpyrazine 15707-24-1 3136 534 77
2,5-Dimethylpyrazine 123-32-0 3272 2210 76
2,6-Dimethoxyphenol 91-10-1 3137 2233 72
2-Ethoxy-3,5-(or 6)-methylpyrazine 65504-94-1 3569 11921 79
2-Ethyl-3,(5 or 6)-dimethylpyrazine 13925-07-0 3149 727 77
2-Ethyl-3-methylpyrazine 15707-23-0 3155 548 76
2-Heptanone 110-43-0 2544 136 28
2-Methoxy-4-methylphenol 93-51-6 2671 175 71
2-Methyl-2-pentenoic acid 3142-72-1 5289 12
2-Methylbutyric acid 116-53-0 2695 2002 25
2-Pentanone 107-87-9 2842 754 27
2-Propanethiol 75-33-2 3897 11565 51
3,7-Dimethyl-1,3,6-octatriene 13877-91-3 3539 11741 13
3-Carbomethoxy pyridine 93-60-7 3709 13
3-Ethylpyridine 536-78-7 3394 11386 13
3-Methyl pentanoic acid 105-43-1 3437 10149 26
3-Methyl-2-butanol 598-75-4 3703 30
3-Methyl-butyraldehyde 590-86-3 2692 94 25
3-Propylidenephthalide 17369-59-4 2952 494 11
4-(Para-hydroxyphenyl)-2-
butanone
5471-51-2 2588 755 72genotoxicity assays, eugenol shows mixed results, although most
of them are negative (EFSA, 2009). Eugenol did not show carcino-
genic activity in rats and mice, when administered orally (FDA,
1983; Miller et al., 1983). It has been argued that eugenol is posi-
tive in some genotoxicity tests but not carcinogenic, because it
only causes one type of mutation due to one type of DNA adduct
(however, for cancer, several mutations are required). This one
adduct may stimulate repair mechanisms that have antigenotoxic
effects. This could explain the equivocal results in geneotoxicity
testing (Tisserand and Young, 2014).
Taken together, the results suggest that adding ingredients to
kretek cigarettes at typical use levels does not adversely alter the
smoke chemistry or in vitro biological effects normally associated
with exposure to mainstream kretek cigarette smoke.
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28664-35-9 3634 243 1 3
4-Carvomenthenol 562-74-3 2248 2229 439 172.515 2 6 1 3
4-Ethylguaiacol 2785-89-9 2436 176 716 172.515 1 3 3 9
4-Methyl-5-thiazoleethanol 137-00-8 3204 11621 1031 3 9 5 15
4-Methylacetophenone 122-00-9 2677 156 807 172.515 7 21 1 3
5-Methylquinoxaline 13708-12-8 3203 2271 798 1 3
6-Methyl-5-hepten-2-one 110-93-0 2707 149 1120 172.515 1 3 1 3
Acetanisole 100-06-1 2005 570 810 172.515 1 3 1 3
Acetic acid 64-19-7 2006 2 81 184.1005 22 66 23 69
Acetoin 513-86-0 2008 749 405 182.60 2 6 1 3
Acetophenone 98-86-2 2009 138 806 172.515 5 15 9 27
Acetyl propionyl 600-14-6 2841 2039 410 172.515 1 3 1 3
Acetylpyrazine 22047-25-2 3126 2286 784 1 3 1 3
A–D-glucose 50-99-7 1 3
Allspice oil (pimenta berry) 8006-77-7 2018 335 182.20 188 564 1 3
Allyl hexanoate 123-68-2 2032 2181 3 172.515 4 12 51 153
Alpha iso-methyl ionone 127-51-5 2714 169 404 172.515 1 3
Alpha-ionone 127-41-3 2594 141 388 172.515 3 9 5 15
Alpha-methyl benzyl acetate 93-92-5 2684 573 801 172.515 1 3
Alpha-pinene 80-56-8 2902 2113 1329 172.515 1 3 13 39
Alpha-terpineol 98-55-5 3045 62 366 172.515 1 3
Amyl acetate 628-63-7 211 1 3
Amyl formate 638-49-3 2068 497 119 172.515 22 66 2 6
Amyl hexanoate 540-07-8 2074 315 163 1752.515 3 9
Amyris balsamifera extract 8015-65-4 33 172.510 1 3
Angelica root oil 8015-64-3 2088 56 182.20 3 9 1 3
Anise oil extract 8007-70-3 2094 46 138
Anisyl acetate 104-21-2 2098 209 873 172.515 1 3 2 6
Anisyl alcohol 105-13-5 2099 66 2001 172.515 3 9
Anisyl alcohol 1331-81-3 7 21
Apple juice concentrate 85251-63-4 1 3
Ascorbic acid 50-81-7 2109 27 182.3013 1 3 1 3
Basil oil 8015-73-4 2119 308 182.20 2 6
Benzaldehyde 100-52-7 2127 101 22 182.60 93 279 2 6
Benzoic acid 65-85-0 2131 21 850 184.1021 1 3 18 54
Benzoin, resinoid 9000-05-9 2133 439 182.20 32 96 1 3
Benzoin, resinoid 9000-72-0 2 6
Benzyl acetate 140-11-4 2135 204 23 172.515 1 3 4 12
Benzyl alcohol 100-51-6 2137 58 25 172.515 522 1566 68 204
Benzyl benzoate 120-51-4 2138 262 24 172.515 171 513 2 6
Benzyl butyrate 103-37-7 2140 277 843 172.515 1 3
Benzyl cinnamate 103-41-3 2142 331 670 172.515 7 21 1 3
Benzyl isovalerate 103-38-8 2152 453 845 172.515 2 6
Benzyl propionate 122-63-4 2150 413 842 172.515 1 3
Benzyl salicylate 118-58-1 2151 436 904 172.515 1 3
Bergamot oil 8007-75-8 2153 137 182.20 20 60
Beta-caryophyllene 87-44-5 2252 2118 1324 172.515 124 372 2 6
Beta-damascenone 23696-85-7 3420 11197 387 1 3 1 3
Trans-beta-damascone 23726-91-2 3243 5 15
Cis-beta-damascone 23726-92-3 2340 384 5 15
Beta-ionone 14901-07-6 2595 142 389 172.515 1 3 1 3
Beta-pinene 127-91-3 2903 2144 1330 172.515 10 30
Bisabolene 495-62-5 3331 10979 1336 2 6
Bornyl acetate 76-49-3 2159 2157 1387 172.515 1 3
Buchu leaves oil 68650-46-4 2169 85 172.510 2 6
Butaraldehyde 123-72-8 2219 91 86 172515 1 3 1 3
Butyl alcohol 71-36-3 2178 52 85 172.515 8 24 3 9
Butyl butyrate 109-21-7 2186 268 151 172.515 20 60 1 3
Butyl butyryllactate 7492-70-8 2190 2107 935 172.515 1 3
Butyl hexanoate 626-82-4 2201 313 162 172.515 1 3 1 3
Butyl isovalerate 109-19-3 2218 444 198 172.515 2 6
Butyric acid 107-92-6 2221 5 87 182.60 52 156 8 24
Camphene 79-92-5 2229 2227 1323 172.515 2 6
Caramel color 8028-89-5 2235 182.1235 76 228 53 159
Caraway oil 8000-42-8 2238 112 182.20 1 3
Cardamom seed oil 8000-66-6 2241 180 182.20 1 3 1 3
Carob bean extract 84961-45-5 2243 120 182.20 1 3 24 72
Cassia bark extract 84961-46-6 2290 133 182.20 102 306
Cassia oil 8007-80-5 2258 131 182.20 2 6 2 6
Cedarwood oil 8000-27-9 252 1 3
Celery seed oil 8015-90-5 2271 52 182.20 3 9
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Chamomile ﬂower, roman, extract 8015-92-7 2275 48 182.20 1 3 1 3
Cherry juice concentrate 89997-53-5 80 240
Chicory extract 68650-43-1 2280 127 182.20 25 75
Cinnamaldehyde 104-55-2 2286 102 656 182.60 306 918 6 18
Cinnamic acid 621-82-9 2288 22 657 172.515 4 12 1 3
Cinnamon bark extract 977038-60-0 2290 133 182.20 459 1377
Cinnamon bark oil 8015-91-6 2292 133 182.20 49 147 1 3
Cinnamyl acetate 103-54-8 2293 208 650 172.515 2 6 3 9
Cinnamyl alcohol 104-54-1 2294 65 647 172.515 1 3 2 6
Cinnamyl cinnamate 122-69-0 2298 332 673 172.515 1 3
Cis-3-hexen-1-yl acetate 3681-71-8 3171 644 134 1 3 1 3
Cis-3-hexenol 928-96-1 2563 750 315 172.515 2 6 1 3
Cis-3-hexenyl lactate 61931-81-5 3690 10681 934 1 3
Citral 5392-40-5 2303 109 1225 182.60 1 3 8 24
Citric acid monohydrate 5949-29-1 218 5 15 6 18
Citric acid 77-92-9 2306 20 218 184.1033 6 18 5 15
Citronella oil 106-22-9 17 51 1 3
Citronellyl acetate 150-84-5 2311 202 57 172.515 1 3
Clary oil 8016-63-5 2321 415 182.20 4 12
Clary sage oil 84775-83-7 2321 415 182.20 1 3
Clove bud extract oleoresin 695 2085
Clove bud ﬂuid extract 1 3
Clove oil 8000-34-8 2325 188 184.1257 441 1323 1 3
Cocoa and cocoa products 977075-45-8 4 12
Cocoa extract 84649-99-0 25 75 37 111
Cocoa powder 95009-22-6 335 1005
Cocoa shell extract 8002-31-1 1 3 207 621
Coffee bean oil 8001-67-0 148 172 516
Coffee extract 68916-18-7 21 63
Coffee extract 84650-00-0 182.20 1 3 577 1731
Cognac oil, green 8016-21-5 2331 182.50 12 36 3 9
Commiphora myrrha extract 8016-37-3 2766 150 172.510 1 3
Copaiba oil 8013-97-6 1 3 1 3
Coriander oil 8008-52-4 2334 154 182.20 4 12 1 3
Costus root oil 8023-88-9 2336 53 172.510 1 3
Cubeb oil 8007-87-2 2339 345 172.510 3 9
Cumin oil 8014-13-9 2343 161 182.20 1 3 1 3
Cyclohexyl acetate 622-45-7 2349 217 1093 172.515 1 3
Methyl-cyclopentenolone anhydre 765-70-8 2700 758 418 172.515 6 18
Davana oil 8016-03-3 2359 69 - 172.510 1 3 1 3
Decanal 112-31-2 2362 98 104 182.60 1 3
Decanoic acid 334-48-5 2364 11 105 172.860 1 3 1 3
Delta-decalactone 705-86-2 2361 621 232 172.515 7 21 1 3
Delta-dodecalactone 713-95-1 2401 624 236 172.515 1 3
Delta-octalactone 698-76-0 3214 2195 228 1 3
Delta-undecalatone 710-04-3 3294 688 234 2 6
Diacetin 25395-31-7 2 6
Diacetyl 431-03-8 2370 752 408 1 3 1 3
Diethyl malonate 105-53-3 2375 2106 614 172.515 1 3 1 3
Diethyl sebacate 110-40-7 2376 623 624 172.515 1 3
Dihydrocarvyl acetate 20777-49-5 2380 2064 379 172.515 3 9
Dimethyl benzyl carbinyl butyrate 10094-34-5 2394 2084 1656 172.515 3 9
D-Limonene 5989-27-5 2633 491 1326 182.60 1 3
DL-Menthone 89-80-5 4 12
Ethyl 2-methylbutyrate 7452-79-1 2443 265 206 172.515 2 6 1 3
Ethyl 2-octenoate 2351-90-8 1 3
Ethyl 3-hydroxybutyrate 5405-41-4 3428 10596 594 1 3
Ethyl 3-hydroxyhexanoate 2305-25-1 3545 11764 601 1 3
Ethyl acetate 141-78-6 2414 191 27 182.60 11 33 355 1065
Ethyl acetoacetate 141-97-9 2415 240 595 172.515 7 21 1 3
Ethyl benzoate 93-89-0 2422 261 852 172.515 1 3 1 3
Ethyl butyrate 105-54-4 2427 264 29 182.60 2730 8190 9 27
Ethyl cinnamate 103-36-6 2430 323 659 172.515 2 6 1 3
Ethyl decanoate 110-38-3 2432 309 35 172.515 89 267 12 36
Ethyl formate 109-94-4 2434 339 26 184.1295 1 3 34 102
Ethyl heptanoate 106-30-9 2437 365 32 172.515 37 111 3 9
Ethyl hexanoate 123-66-0 2439 310 31 172.515 8 24
Ethyl isobutyrate 97-62-1 2428 288 186 172.515 3 9 1 3
Ethyl isovalerate 108-64-5 2463 442 196 172.515 79 237
Ethyl laurate 106-33-2 2441 375 37 172.515 156 468 7 21
Ethyl maltol 4940-11-8 3487 692 1481 172.515 97 291 5 15
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Ethyl myristate 124-06-1 2445 385 38 172.515 20 60 6 18
Ethyl nonanoate 123-29-5 2447 388 34 172.515 1 3
Ethyl octanoate 106-32-1 2449 392 33 172.515 51 153 3 9
Ethyl oleate 111-62-6 2450 633 345 172.515 74 222 5 15
Ethyl palmitate 628-97-7 2451 634 39 8 24
Ethyl phenylacetate 101-97-3 2452 2156 1009 172.515 2 6
Ethyl propionate 105-37-3 2456 402 28 172.515 3 9 174 522
Ethyl salicylate 118-61-6 2458 432 900 172.515 1 3
Ethyl trans-2, cis-4-decadienoate 3025-30-7 3148 10574 1192 1 3
Ethyl valerate 539-82-2 2462 465 30 172.515 1 3
Ethyl vanillin 121-32-4 2464 108 893 182.60 28 84 6 18
Eugenol 97-53-0 2467 171 1529 184.1257 1048 3144 1 3
Eugenyl acetate 93-28-7 2469 210 1531 172.515 138 414
Fenugreek absolute 84625-40-1 2485 460 182.20 44 132 17 51
Fenugreek extract 68990-15-8 2484 460 182.10 4 12 266 798
Furaneol 3658-77-3 3174 1446 1 3 43 129
Galangal (chinese ginger) oleoresin 8024-40-6 2500 29 172.510 3 9
Galbanum oil 8023-91-4 2501 197 172.510 1 3
Gamma-decalactone 706-14-9 2360 2230 231 172.515 3 9 1 3
Gamma-heptalactone 105-21-5 2539 2253 225 172.515 1 3 1 3
Gamma-hexalactone 695-06-7 2556 2254 223 172.515 1 3 1 3
Gamma-nonalactone 104-61-0 2781 178 229 172.515 1 3 13 39
Gamma-octalactone 104-50-7 2796 2274 226 172.515 1 3 13 39
Gamma-undecalactone 104-67-6 3091 179 233 172.515 4 12 1 3
Gamma-valerolactone 108-29-2 3103 757 220 1 3 1 3
Geraniol 106-24-1 2507 60 1223 182.60 2 6 1 3
Geranium rose oil 8000-46-2 1 3 1 3
Geranyl acetate 105-87-3 2509 201 58 182.60 1 3
Geranyl isovalerate 109-20-6 2518 448 75 172.515 1 3
Geranyl phenylacetate 102-22-7 2516 231 1020 172.515 1 3
Geranyl propionate 105-90-8 2517 409 62 172.515 1 3
Ginger extract 8002-60-6 2521 489 182.20 13 39
Ginger oil 8007-08-7 2522 489 1 3 1 3
Guaiac wood oil 8016-23-7 2534 220 172.510 1 3
Guaiacol 90-05-1 2532 173 713 172.515 1 3 10 30
Helianthus annuus oil 8001-21-6 1 3
Heptanoic acid 111-14-8 3348 28 96 1 3 1 3
Hexanal 66-25-1 2557 96 92 172.515 1 3
Hexanoic acid 142-62-1 2559 9 93 172.515 13 39 3 9
Hexen-2-al 6728-26-3 2560 748 1353 748 3 9 1 3
Hexenyl formate cis-3 33467-73-1 3353 123 1 3
Hexyl acetate 142-92-7 2565 196 128 172.515 1 3
Hexyl alcohol 111-27-3 2567 53 91 172.515 1 3
Immortelle absolute 90045-56-0 6 18
Immortelle extract 8023-95-8 2592 - - 182.20 10 30
Irone alpha 79-69-6 2597 145 403 172.515 1 3
Isoamyl acetate 123-92-2 2055 214 43 172.515 54 162 4100 12300
Isoamyl alcohol 123-51-3 2057 51 52 172.515 9 27 110 330
Isoamyl butyrate 106-27-4 2060 282 45 172.515 272 816 31 93
Isoamyl caprylate 2035-99-6 2080 401 47 172.515 1 3
Isoamyl hexanoate 2198-61-0 2075 320 46 172.515 2 6 3 9
Isoamyl isovalerate 659-70-1 2085 458 50 172.515 247 741 4 12
Isoamyl phenylacetate 102-19-2 2081 2161 1014 172.515 1 3
Isoamyl propionate 105-68-0 2082 417 44 172.515 30 90 2 6
Isobutyl alcohol 78-83-1 2179 49 251 172.515 44 132
Isobutyl phenylacetate 102-13-6 2210 2160 1013 172.515 1 3 1 3
Isobutyraldehyde 78-84-2 2220 92 252 172.515 1 3
Isobutyric acid 79-31-2 2222 6 253 172.515 1 3
Isovaleric acid 503-74-2 3102 8 259 8 24 7 21
Jackfruit extract 4 12
Jasmine absolute 8022-96-6 2600 245 182.20 1 3
Kola nut extract 68916-19-8 2607 - 182.20 4 12
Labdanum absolute 8016-26-0 2609 134 172.515 7 21 4 12
Lactic acid 598-82-3 930 10 30 213 639
Lactone c-04 gamma 96-48-0 3291 615 219 1 3
Lauric acid 143-07-7 2614 12 111 172.860 1 3 1 3
Lavender oil 8000-28-0 2622 257 182.20 1 3
Lemon oil 8008-56-8 2625 139 182.20 87 261
Lemon extract 84929-31-7 2623 139 182.20 1 3 65 195
Lemon verveine 977047-96-3 1 3
Licorice extract 68916-91-6 2630 218 184.1408 1 3 3844 9610
Linalool 78-70-6 2635 61 356 182.60 6 18 1 3
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Linalyl acetate 115-95-7 2636 203 359 182.60 30 90 1 3
Linoleic acid 60-33-3 694 332 184.1065 1 3
L-Lactic acid 79-33-4 2611 4 930 184.1061 10 30 213 639
L-Lenthol natural 2216-51-5 2665 63 427 172.515 2 6 3997 11991
L-Lenthone 14073-97-3 2267 2035 429 172.515 1 3
Lovage extract 8016-31-7 2651 261 172.510 2 6 12 36
Mace oil 8007-12-3 2653 296 182.20 40 120 1 3
Maltol 118-71-8 2656 148 1480 172.515 3 9 2 6
Mate absolute 68916-96-1 237 182.20 3 9
Mate absolute 73296-98-7 237 182.20 1 3 3 9
m-Mimethoxybenzene 151-10-0 2385 189 1249 172.515 1 3 1 3
Menthyl acetate 89-48-5 2668 206 431 172.515 1 3
Menthyl isovalerate 16409-46-4 2669 450 432 172.515 3 9
Methoxy-3-methylpyrazine
(mixture of isomer)
2847-30-5 3183 2266 788 1 3 1 3
Methyl 2-hexenoate 13894-63-8 2709 583 172.515 1 3
Methyl 2-methylbutyrate 868-57-5 2719 2085 205 172.515 1 3
Methyl 2-octynoate 111-12-6 2729 481 1357 172.515 1 3
Methyl 3-methylthiopropionate 13532-18-8 2720 428 472 172.515 1 3
Methyl acetate 79-20-9 2676 213 125 172.515 1 3 5 15
Methyl benzoate 93-58-3 2683 260 851 172.515 1 3 1 3
Methyl caproate 106-70-7 2708 319 1871 172.515 2 6
Methyl caprylate 111-11-5 2728 398 173 172.515 1 3
Methyl cinnamate 103-26-4 2698 333 658 172.515 1 3 1 3
Methyl dihydrojasmonate 24851-98-7 3408 10785 1 3
Methyl heptanoate 106-73-0 2705 368 167 172.515 1 3
Methyl phenylacetate 101-41-7 2733 2155 1008 172.515 1 3
Methyl salicylate 119-36-8 2745 433 899 2 6
Methyl sulﬁde 75-18-3 2746 483 452 172.515 2 6 1 3
Methyl-cyclopentenolone (maple
lactone)
80-71-7 2700 758 418 172.515 36 108 6 18
Molasses, blackstrap 8052-35-5 S2 1 3
Myristic acid 544-63-8 2764 16 113 172.860 1 3
Nerol 106-25-2 2770 2018 1224 172.515 1 3 1 3
Neroli oil 8016-38-4 2771 136 182.20 1 3
Nonanoic acid 112-05-0 2784 29 102 172.515 15 45 1 3
Nootkatone 4674-50-4 3166 11164 1398 172.515 1 3 71 213 1 3
Oakmoss absolute 9000-50-4 2795 194 172.510 1 3
Octanoic acid 124-07-2 2799 10 99 184.1025 1 3 1 3
Oleic acid 112-80-1 2815 13 333 172.860 60 180
Orange oil (distillated) 65996-98-7 1 3
Orange oil terpenes 68647-72-3 2824 16 48
Orange oil terpenes 68917-57-7 2824 143 84 252
Orange oil, sweet 8008-57-9 2825 143 224 672 1 3
Orange peel sweet oil terpeneless 8028-48-6 2824 124 372 1 3
Origanum oil 8007-11-2 2828 454 182.20 1 3
Orris root extract 8002-73-1 2830 241 172.515 1 3
Palmarosa oil 8014-19-5 2831 40 182.20 1 3 1 3
Palmitic acid natural 57-10-3 2832 14 115 172.860 1 3
Para-cymene 99-87-6 2356 620 1325 172.515 1 3 1 3
Para-methoxybenzaldehyde 123-11-5 2670 103 878 172.515 3 9 8 24
Para-tolyl acetate 140-39-6 3073 226 699 172.515 1 3 1 3
Patchouli oil 8014-09-3 2838 353 172.510 1 3
Pepper oil, black 8006-82-4 2845 347 182.20 30 90 2 6
Peppermint oil 8006-90-4 2848 282 182.20 3 9
Petitgrain oil 8014-17-3 2854 1 3
Phenethyl acetate 103-45-7 2857 221 989 172.515 1 3 1 3
Phenethyl alcohol 60-12-8 2858 68 987 172.515 2 6 3 9
Phenethyl butyrate 103-52-6 2861 506 991 172.515 1 3
Phenethyl cinnamate 103-53-7 2863 336 671 172.515 3 9 1 3
Phenethyl isobutyrate 103-48-0 2862 302 992 172.515 1 3 5 15
Phenethyl isovalerate 140-26-1 2871 461 994 172.515 8 24
Phenethyl tiglate 55719-85-2 2780 2186 997 172.515 1 3 1 3
Phenyl acetaldehyde dimethyl acetal 101-48-4 2876 40 1003 172.515 2 6
Phenylacetaldehyde 122-78-1 2874 116 1002 172.515 1 3 1 3
Phenylacetic acid 103-82-2 2878 672 1007 172.515 10 30 5 15
Pine needle oil 8021-29-2 2905 5 172.510 1 3
Pine oil, scotch 8023-99-2 2906 341 172.510 1 3
Pineapple extract 4 12
Piperonal 120-57-0 2911 104 896 182.60 163 489 3 9
p-Mentha-8-thiol-3-one 38462-22-5 3177 561 1 3
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Mainstream smoke constituent concentrations per cigarette.
Analyte Unit 2R4F Control Mix A low Mix A high
M SE N M SE N M SE N M SE N
ISO parameters
Puff count 8.08 0.05 4 15.4 0.1 4 16.2 0.1 4 15.4 0.2 4
TPM mg/cig. 9.62 0.12 4 34.7 0.7 4 34.6 0.2 4 35.0 0.4 4
Tar mg/cig. 7.83 0.1 4 29.6 0.6 4 29.3 0.2 4 29.7 0.4 4
Nicotine mg/cig. 0.713 0.01 4 2.13 0.04 4 2.12 0.01 4 2.00 0.03 4
Water mg/cig. 1.08 0.03 4 3.00 0.11 4 3.17 0.03 4 3.28 0.04 4
Carbon monoxide mg/cig. 11.1 0.3 4 19.2 0.5 4 18.8 0.2 4 18.1 0.2 4
Aldehydes
Formaldehyde lg/cig. 15.8 0.7 5 46.6 1.1 10 47.5 0.7 10 48.2 1.1 10
Acetaldehyde lg/cig. 498 17 5 716 14 10 741 6 10 698 10 10
Acrolein lg/cig. 53.2 1.8 5 91.5 1.7 10 95.0 1.1 10 91.6 1.5 10
Propionaldehyde lg/cig. 44.5 1.3 5 73.9 1.5 10 76.2 1.0 10 73.8 1.0 10
Crotonaldehyde lg/cig. 10.1 0.4 5 21.4 0.8 10 23.3 0.6 10 22.4 0.5 10
Aliphatic dienes
1,3-Butadiene lg/cig. 39.2 1.1 4 82.1 0.7 5 80.1 1.5 5 82.4 3.6 5
Isoprene lg/cig. 391 10 4 533 13 5 535 15 5 523 13 5
Acid derivatives
Acetamide lg/cig. 3.94 0.06 4 10.9 0.3 5 9.93 0.12 5 10.9 0.3 5
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Propenylguaethol 94-86-0 2922 170 1264 172.515 1 3
Propionic acid 79-09-4 2924 3 84 184.1081 1 3 19 57
Propyl acetate 109-60-4 2925 192 126 172.515 1 3
Prune juice (concentrate) 90082-87-4 586 1758
Pyruvic acid 127-17-3 2970 19 936 172.515 7 21
Rhodinol 6812-78-8 2980 76 1222 172.515 1 3 1 3
Rose absolute 8007-01-0 2988 1 3
Rum ﬂavour, non-alcoholic 90604-30-1 1 3
Salicylaldehyde 90-02-8 3004 605 897 172.515 1 3 1 3
Sandalwood oil, yellow 8006-87-9 3005 420 172.510 1 3
Sandalwood oil, yellow 84787-70-2 1 3
Sodium benzoate 532-32-1 3025 184.1733 3 9
Star anise oil 68952-43-2 2096 238 182.60 13 39
Storax 8046-19-3 3036 265 172.510 1 3 1 3
Styrax benzoin gum 2593-35-2 1 3
Styrax extract 8024-01-9 1 3 1 3
Sugar: high fructose corn syrup 42% 8029-43-4 14 42
Sugar: invert sugar 8013-17-0 7989 19975
Sugar: sucrose 57-50-1 269 807 10 30
Tabanon 13215-88-8 4663 4 12
Tagetes oil 8016-84-0 3040 443 172.510 1 3
Tangerine oil 8008-31-9 3041 182.20 1 3
Tea extract 84650-60-2 277 1 3 14 42
Terpinolene 586-62-9 3046 2115 1331 172.515 1 3 1 3
Terpinyl acetate 8007-35-0 3047 205 368 172.515 2 6
Terpinyl acetate 80-26-2 2 6
Thymol 89-83-8 3066 174 709 172.515 2 6
Tolu balsam gum 9000-64-0 3070 297 172.510 219 657 2 6
Trans-2-hexenol 928-95-0 1 3 1 3
Trans-anethole 4180-23-8 2086 183 217 182.60 221 663
Triacetin 102-76-1 2007 920 184.1901 75 225 9 27
Triethyl citrate 77-93-0 3083 629 184.1911 480 1440 1 3
Valencene 4630-07-3 3443 11030 1337 2 6
Valeraldehyde 110-62-3 3098 93 89 172.515 1 3 1 3
Valerian root extract 8057-49-6 3100 473 172.510 13 39
Valerian root oil 8008-88-6 3100 473 172.510 1 3
Valeric acid 109-52-4 3101 7 90 172.515 1 3 1 3
Vanilla extract 8024-06-4 3104 474 182.10 51 153 2 6
Vanilla infusion 8047-24-3 1 3
Vanillin 121-33-5 3107 107 889 182.60 29 87 87 261
Veratraldehyde 120-14-9 3109 106 877 172.515 1 3 1 3
Remarks: CAS number, numerical identiﬁer assigned by Chemical Abstracts Service; FEMA number, numerical identiﬁer assigned by Flavor and Extract Manufacturers
Association, JECFA number, numerical identiﬁer assigned by Joint FAO/WHO Expert Committee on Food Additives; CFR number, numerical identiﬁer assigned by Code of
Federal Regulation, USA.
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Analyte Unit 2R4F Control Mix A low Mix A high
M SE N M SE N M SE N M SE N
Acrylamide lg/cig. 1.56 0.03 4 4.32 0.18 5 3.81 0.15 5 4.26 0.26 5
Acrylonitrile lg/cig. 28.0 0.2 4 52.0 0.9 5 51.2 1.2 5 51.8 2.0 5
Nitro compounds
2-Nitropropane ng/cig. 16.8 0.4 4 19.7 0.6 4 20.9 0.7 4 19.8 0.7 4
Aromatic amines
o-Toluidine ng/cig. 49.4 0.5 8 47.7 0.5 8 47.2 0.8 8 47.3 0.5 8
o-Anisidine ng/cig. 2.05 0.02 8 1.45 0.05 8 1.42 0.06 7 1.41 0.02 8
2-Naphthylamine ng/cig. 5.57 0.1 8 4.99 0.15 8 5.19 0.18 8 4.97 0.05 8
4-Aminobiphenyl ng/cig. 1.04 0.03 8 0.844 0.03 8 0.927 0.047 7 1.01 0.02 7
Halogen compounds
Vinyl chloride ng/cig. 34.9 0.8 4 5 65.9 1.7 5 76.1 1.6 5 66.9 2.2 5
Inorganic compounds
Nitrogen oxides lg/cig. 227 1 4 5 151 3 5 155 4 5 148 2 5
Hydrogen cyanide lg/cig. 81.6 3.2 4 4 194 5 4 187 8 4 194 4 4
Monocyclic aromatic hydrocarbons
Benzene lg/cig. 45.6 1.6 4 87.6 1.7 5 87.8 0.9 5 92 2.2 5
Toluene lg/cig. 78.5 1 4 129 3 5 127 1 5 135 3 5
Styrene lg/cig. 6.16 0.16 4 13.7 0.2 5 14.2 0.1 5 15.9 0.4 5
Volatile N-nitrosamines
NDMA ng/cig. <5.00 4 <5.00 4 <5.00 4 <5.00 4
NMEA ng/cig. <10.0 4 <10.0 4 <10.0 4 <10.0 4
NDEA ng/cig. <7.00 4 <7.00 4 <7.00 4 <7.00 4
NPRA ng/cig. <11.0 4 <11.0 4 <11.0 4 <11.0 4
NBUA ng/cig. <9.00 4 <9.00 4 <9.00 4 <9.00 4
NPY ng/cig. <7.00 4 <7.00 4 <7.00 4 <7.00 4
NPI ng/cig. <8.00 4 <8.00 4 <8.00 4 <8.00 4
Tobacco-speciﬁc N-nitrosamines
NNN ng/cig. 113 8 4 36.7 3.5 10 34.6 2.4 10 29.2 0.9 10
NNK ng/cig. 105 7 4 17.9 1.6 10 17.6 1.0 10 14.7 0.6 10
Phenols
Phenol lg/cig. 8.13 0.2 4 48.8 0.6 5 45.6 0.5 5 45.5 0.8 5
Catechol lg/cig. 39.3 1.2 4 131 1 5 127 1 5 124 1 5
Hydroquinone lg/cig. 29.3 0.9 4 80.3 0.9 5 79.1 1.1 5 76.5 1 5
Eugenol mg/cig. 0 4 5.57 0.1 5 5.29 0.21 5 5.23 0.05 5
Polycyclic aromatic hydrocarbons
Pyrene ng/cig. 37.8 0.4 4 141 3 5 154 3 5 145 4 5
Benz[a]anthracene ng/cig. 12.5 0.1 4 45.6 1.0 5 48.7 0.9 5 48.0 1.0 5
Benzo[b]ﬂuoranthene ng/cig. 5.05 0.05 4 17.5 0.4 5 18.6 0.3 5 18.1 0.4 5
Benzo[j]ﬂuoranthene ng/cig. 3.18 0.06 4 12.0 0.2 5 12.6 0.3 5 12.3 0.4 5
Benzo[k]ﬂuoranthene ng/cig. 1.97 0.04 4 7.26 0.21 5 7.78 0.18 5 7.29 0.24 5
Benzo[a]pyrene ng/cig. 6.82 0.07 4 25.1 0.5 5 26.8 0.4 5 26.3 0.5 5
Dibenz[a,h]anthracene ng/cig. <0.970 4 1.53 0.05 5 1.48 0.05 5 1.64 0.05 5
Dibenzo[a,e]pyrene ng/cig. 0.19 0.007 4 0.674 0.02 5 0.7 0.025 5 0.654 0.012 5
Dibenzo[a,h]pyrene ng/cig. <0.230 4 0.78 0.02 5 0.836 0.032 5 0.78 0.027 5
Dibenzo[a,i]pyrene ng/cig. <0.220 4 0.562 0.01 5 0.606 0.021 5 0.574 0.022 5
Dibenzo[a,l]pyrene ng/cig. <0.190 4 <0.190 5 <0.190 5 <0.190 5
Indeno(1,2,3-cd)pyrene ng/cig. 2.89 0.06 4 10.6 0.2 5 11.1 0.2 5 10.8 0.3 5
5-Methylchrysene ng/cig. <0.400 4 <0.400 5 <0.400 5 <0.400 5
Metals
Arsenic ng/cig. 2.79 0.09 4 <4.31 4 <4.31 4 <4.31 4
Cadmium ng/cig. 38.8 1.1 4 102 2 4 103 3 4 98.2 1.5 4
Chromium ng/cig. <1.60 4 <4.92 4 <4.92 4 6.06 4
Nickel ng/cig. <2.10 4 <6.46 4 <6.46 4 <6.46 4
Lead ng/cig. 11.2 0.4 4 17.3 0.3 4 17.8 0.7 4 19.5 0.4 4
Parameter Unit Mix B low Mix B high Mix C low Mix C high
M SE N M SE N M SE N M SE N
ISO parameters
Puff count 15.4 0.3 4 14.6 0.1 4 15.7 0.2 4 15.5 0.2 4
TPM mg/cig. 34.4 0.4 4 34.7 0.5 4 35.9 0.7 4 36.6 0.9 4
Tar mg/cig. 29.5 0.4 4 29.9 0.3 4 30.6 0.7 4 31.4 0.9 4
Nicotine mg/cig. 2.04 0.01 4 1.98 0.02 4 2.03 0.02 4 2.06 0.02 4
Water mg/cig. 2.95 0.05 4 2.84 0.14 4 3.27 0.09 4 3.14 0.09 4
Carbon monoxide mg/cig. 19.7 0.2 4 18.5 0.5 4 18.5 0.2 4 18.7 0.3 4
Aldehydes
Formaldehyde lg/cig. 46.3 1.3 10 50.3 0.5 10 45.4 1.3 10 46.5 1.4 10
Acetaldehyde lg/cig. 747 14 10 721 11 10 710 18 10 716 18 10
Acrolein lg/cig. 99 2 10 94.2 1.3 10 90.9 2.5 10 92.1 2.5 10
(continued on next page)
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Table B (continued)
Parameter Unit Mix B low Mix B high Mix C low Mix C high
M SE N M SE N M SE N M SE N
Propionaldehyde lg/cig. 79.6 1.1 10 75.2 1.2 10 73.1 1.7 10 76.7 2 10
Crotonaldehyde lg/cig. 22.8 0.9 10 20.8 0.8 10 22.3 0.7 10 22.2 0.5 10
Aliphatic dienes
1,3-Butadiene lg/cig. 82.2 3.2 5 75.5 1.5 5 89.7 1.4 5 83.4 2.1 5
Isoprene lg/cig. 543 10 5 502 8 5 554 15 5 523 8 5
Acid derivatives
Acetamide lg/cig. 11.6 0.3 5 10.2 0.2 5 12.1 0.2 5 12 0.1 5
Acrylamide lg/cig. 4.08 0.25 5 4.32 0.14 5 4.15 0.24 5 4.08 0.2 5
Acrylonitrile lg/cig. 52.8 1.6 5 48.2 1.3 5 54.9 1.7 5 53 0.6 5
Nitro compounds
2-Nitropropane ng/cig. 21 0.9 4 21.7 1.2 4 19.6 0.5 4 20.9 1.2 4
Aromatic amines
o-Toluidine ng/cig. 48.8 0.6 8 46.6 0.5 8 47.5 0.8 8 48.4 0.8 8
o-Anisidine ng/cig. 1.51 0.05 8 1.45 0.04 8 1.43 0.03 8 1.48 0.05 8
2-Naphthylamine ng/cig. 5.41 0.12 8 5.37 0.07 8 4.9 0.15 8 5.21 0.21 8
4-Aminobiphenyl ng/cig. 0.945 0.027 8 1 0.02 7 0.849 0.027 8 0.875 0.035 8
Halogen compounds
Vinyl chloride ng/cig. 67.8 2.6 5 64.1 1.9 5 77.3 2.4 5 77.4 2.8 5
Inorganic compounds
Nitrogen oxides lg/cig. 149 1 5 146 3 5 149 3 5 149 3 5
Hydrogen cyanide lg/cig. 207 7 4 196 9 4 199 5 4 194 5 4
Monocyclic aromatic hydrocarbons
Benzene lg/cig. 88.5 1.7 5 81.8 1.9 5 92.9 1.4 5 85.9 0.9 5
Toluene lg/cig. 128 3 5 115 2 5 129 2 5 115 1 5
Styrene lg/cig. 13.7 0.4 5 12.3 0.3 5 14.2 0.3 5 13.2 0.1 5
Volatile N-nitrosamines
NDMA ng/cig. <5.00 4 <5.00 4 <5.00 3 <5.00 4
NMEA ng/cig. <10.0 4 <10.0 4 <10.0 3 <10.0 4
NDEA ng/cig. <7.00 4 <7.00 4 <7.00 3 <7.00 4
NPRA ng/cig. <11.0 4 <11.0 4 <11.0 3 <11.0 4
NBUA ng/cig. <9.00 4 <9.00 4 <9.00 3 <9.00 4
NPY ng/cig. <7.00 4 <7.00 4 <7.00 3 <7.00 4
NPI ng/cig. <8.00 4 <8.00 4 <8.00 3 <8.00 4
Tobacco-speciﬁc N-nitrosamines
NNN ng/cig. 41.1 2.2 10 41.7 1.9 10 42 1.8 10 40.8 2.3 10
NNK ng/cig. 22.1 2.3 10 22.2 2.7 10 20.2 0.7 10 23.3 3.7 10
Phenols
Phenol lg/cig. 46.8 0.6 5 46.7 1 5 49.1 0.6 5 47.6 0.5 5
Catechol lg/cig. 127 1 5 126 2 5 128 1 5 126 1 5
Hydroquinone lg/cig. 77.8 1.3 5 78 1.5 5 77.6 0.4 5 79.2 0.7 5
Eugenol mg/cig. 5.31 0.12 5 6.24 0.05 5 5.67 0.06 5 5.48 0.14 5
Polycyclic aromatic hydrocarbons
Pyrene ng/cig. 144 2 5 148 3 5 143 2 5 148 4 5
Benz[a]anthracene ng/cig. 45.7 0.9 5 46.9 0.9 5 45.4 0.5 5 47.8 1.2 5
Benzo[b]ﬂuoranthene ng/cig. 17.6 0.3 5 18.1 0.3 5 17.3 0.1 5 18 0.4 5
Benzo[j]ﬂuoranthene ng/cig. 12.3 0.3 5 12 0.3 5 12.1 0.2 5 12.2 0.2 5
Benzo[k]ﬂuoranthene ng/cig. 7.73 0.18 5 7.48 0.22 5 7.24 0.2 5 7.41 0.22 5
Benzo[a]pyrene ng/cig. 25.4 0.3 5 25.9 0.4 5 24.9 0.3 5 26.5 0.6 5
Dibenz[a,h]anthracene ng/cig. 1.46 0.06 5 1.55 0.04 5 1.54 0.07 5 1.49 0.04 5
Dibenzo[a,e]pyrene ng/cig. 0.678 0.018 5 0.692 0.018 5 0.682 0.024 5 0.67 0.014 5
Dibenzo[a,h]pyrene ng/cig. 0.778 0.02 5 0.8 0.023 5 0.766 0.016 5 0.818 0.022 5
Dibenzo[a,i]pyrene ng/cig. 0.584 0.009 5 0.594 0.007 5 0.564 0.012 5 0.542 0.02 5
Dibenzo[a,l]pyrene ng/cig. <0.190 5 <0.190 5 <0.190 5 <0.190 5
Indeno(1,2,3-cd)pyrene ng/cig. 10.5 0.2 5 10.7 0.2 5 10.4 0.2 5 10.9 0.3 5
5-Methylchrysene ng/cig. <0.400 5 <0.400 5 <0.400 5 <0.400 5
Metals
Arsenic ng/cig. <4.31 4 <4.31 4 <4.31 4 <4.31 4
Cadmium ng/cig. 98.6 3.9 4 93.9 2.1 4 91.8 1 4 95 4.1 4
Chromium ng/cig. <4.92 4 6.15 4 5.28 4 <4.92 4
Nickel ng/cig. <6.46 4 <6.46 4 <6.46 4 <6.46 4
Lead ng/cig. 17.9 0.5 4 17.1 0.2 4 16.2 0.3 4 17.3 0.3 4
Remarks: N, number of measurements; M, arithmetic mean, SE, standard error.
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Table C






2R4F a Control a Mix A low Mix A high Mix B low Mix B high 2R4F b Control b Mix C low Mix C high
NRU assay, 1/EC50 (ml/cig.)
TPM 112 ± 5 391 ± 5 380 ± 20 368 ± 11 379 ± 8 376 ± 8 110 ± 5 370 ± 14 356 ± 12 366 ± 6
GVP 83 ± 1 122 ± 1 117 ± 3 111 ± 5 122 ± 2 116 ± 1 81 ± 6 112 ± 2 105 ± 4 111 ± 7
Ames assay, slope (revertants/cig.)
TPM
+S9 TA98 29069 ± 814 42716 ± 2292 41964 ± 1722 34965 ± 2491 39463 ± 2581 40316 ± 2246 – – 46131 ± 2006 44798 ± 2125
TA100 13747 ± 800 24998 ± 2224 29696 ± 3054 25451 ± 3027 27330 ± 1675 26178 ± 2161 – – 26300 ± 1993 29253 ± 3046
TA102 29 ± 134 202 ± 697 109 ± 762 237 ± 782 1067 ± 702 1123 ± 690 – – 492 ± 715 208 ± 695
TA1535 18 ± 9 98 ± 40 12 ± 57 118 ± 37 65 ± 56 21 ± 59 – – 36 ± 55 154 ± 63
TA1537 4778 ± 423 6299 ± 921 6413 ± 929 7405 ± 798 7256 ± 1181 6701 ± 790 – – 6281 ± 771 7315 ± 923
S9 TA98 66 ± 27 139 ± 89 109 ± 93 4 ± 91 251 ± 87 163 ± 68 – – 404 ± 121 290 ± 91
TA100 849 ± 177 2368 ± 644 4126 ± 620 3134 ± 660 3085 ± 587 2027 ± 575 – – 1676 ± 679 3167 ± 636
TA102 208 ± 139 439 ± 382 89 ± 532 298 ± 591 54 ± 705 421 ± 655 – – 612 ± 440 322 ± 380
TA1535 2 ± 15 23 ± 51 35 ± 53 33 ± 53 53 ± 55 144 ± 76 – – 65 ± 63 86 ± 77
TA1537 130 ± 20 239 ± 50 244 ± 69 279 ± 71 85 ± 75 187 ± 72 – – 287 ± 69 170 ± 64
MLA assay, 1/C3B (ml/cig.)
TPM






































Remarks: NRU, Neutral Red Uptake Assay; MLA, Mouse Lymphoma Assay; data give means and standard deviations (in case of the MLA, results of the two determinations).
E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S66–S80 S79References
Ames, B.N., Lee, F.D., Durston, W.E., 1973. An improved bacterial test system for the
detection and classiﬁcation of mutagens and carcinogens. Proc. Natl. Acad. Sci.
U.S.A. 70, 782–786.
Ashley, D.L., Burns, D., Djordjevic, M., Dybing, E., Gray, N., Hammond, S.K.,
Henningﬁeld, J., Jarvis, M., Reddy, K.S., Robertson, C., Zaatari, G., 2008. The
scientiﬁc basis of tobacco product regulation. World Health Organ. Tech. Rep.
Ser., 1–277, 271 p following 277.
Baker, R.R., Bishop, L.J., 2004. The Pyrolysis of tobacco ingredients. J. Anal. Appl.
Pyrolysis 71, 223–311.
Baker, R.R., Massey, E.D., Smith, G., 2004. An overview of the effects of tobacco
ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42, Suppl.:
S53–S83.
Baker, R.R., Pereira da Silva, J.R., Smith, G., 2004b. The effect of tobacco ingredients
on smoke chemistry. Part II: casing ingredients. Food Chem. Toxicol. 42, Suppl.:
S39–S52.
Bombick, B.R., Murli, H., Avalos, J.T., Bombick, D.W., Morgan, W.T., Putnam, K.P.,
Doolittle, D.J., 1998. Chemical and biological studies of a new cigarette that
primarily heats tobacco. Part 2. In vitro toxicology of mainstream smoke
condensate. Food Chem. Toxicol. 36, 183–190.
Borenfreund, E., Puerner, J.A., 1985. Toxicity determined in vitro by morphological
alterations and neutral red absorption. Toxicol. Lett. 24, 119–124.
Borenfreund, E., Puerner, J.A., 1987. Short-term quantitative in vitro cytotoxicity
assay involving an S-9 activating system. Cancer Lett. 34, 243–248.
Carmines, E.L., 2002. Evaluation of the potential effects of ingredients added to
cigarettes. Part 1: cigarette design, testing approach, and review of results. Food
Chem. Toxicol. 40, 77–91.
Chen, P.X., Moldoveanu, S.C., 2003. Mainstream smoke chemical analyses for 2R4F
Kentucky reference cigarette. Beitr Tabakforsch Int. 20, 448–458.
Clive, D., Flamm, W.G., Machesko, M.R., Bernheim, N.J., 1972. A mutational assay
system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res.
16, 77–87.
Cole, J., Muriel, W.J., Bridges, B.A., 1986. The mutagenicity of sodium ﬂuoride to
L5178Y [wild-type and TK+/ (3.7.2c)] mouse lymphoma cells. Mutagenesis 1,
157–167.
Davis, H.M., Vaught, A., 1990. Research Cigarettes. The University of Kentucky
Printing Services, Lexington KY, USA.
Dempsey, R., Coggins, C.R., Roemer, E., 2011. Toxicological assessment of cigarette
ingredients. Regul. Toxicol. Pharmacol. 61, 119–128.
DIN, 2014. German Institute for Standardization, DIN Technical Report 133,
Toxicological Evaluation of Additives for Tobacco Products – A Guide (second
revised version 2014, in press). Berlin: Beuth Verlag. German version available
as: DIN, 2014. Deutsches Institute für Normung, DIN SPEC 10133,
Toxikologische Bewertung von Zusatzstoffen für Tabakprodukte - Ein
Leitfaden. Berlin: Beuth Verlag.
EFSA, 2009. Flavouring Group Evaluation 60 (FGE.60) 1: consideration of eugenol
and related hydroxyallylbenzene derivatives evaluated by JECFA (65th meeting)
structurally related to ring-substituted phenolic substances evaluated by EFSA
in FGE.22 (2006). EFSA J ON-965:1–53.FDA, 1983. Carcinogenesis studies of allyl isovalerate (CAS No. 2835–39-4) in F344/
N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser.
253, 1–185.
Gaworski, C.L., Heck, J.D., Bennett, M.B., Wenk, M.L., 1999. Toxicologic evaluation of
ﬂavor ingredients added to cigarette tobacco: skin painting bioassay of cigarette
smoke condensate in SENCAR mice. Toxicology 139, 1–17.
Gaworski, C.L., Oldham, M.J., Wagner, K.A., Coggins, C.R., Patskan, G.J., 2011. An
evaluation of the toxicity of 95 ingredients added individually to experimental
cigarettes: approach and methods. Inhal. Toxicol. 23 (Suppl. 1), 1–12.
Health Canada, 1999. Determination of ‘‘tar’’, nicotine and carbon monoxide in
mainstream smoke. In: Health Canada – Ofﬁcial Method.
Heck, J.D., Gaworski, C.L., Rajendran, N., Morrissey, R.L., 2002. Toxicologic evaluation
of humectants added to cigarette tobacco: 13-week smoke inhalation study of
glycerin and propylene glycol in Fischer 344 rats. Inhal. Toxicol. 14, 1135–1152.
IARC, 1985. Tobacco Smoking. In: Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans, 38. International Agency for
Research on Cancer, Lyon, France.
ISO, 1991a. International Standard ISO 3308, Routineanalytical Cigarette-Smoking
Machine – Deﬁnitions and Standard Conditions, International Organization for
Standardization, Geneva, Switzerland.
ISO, 1991b. International Standard ISO 4387, Determination of Total and Nicotine-
Free Dry Particulate Matter Using Routine Analytical Smoking Machine.
International Organization for Standardization, Geneva, Switzerland.
ISO, 1999. International Standard ISO 3402, Tobacco and Tobacco Products –
Atmosphere for Conditioning and Testing. International Organization for
Standardization, Geneva, Switzerland.
ISO, 2000. International Standard ISO 10315, Cigarettes – Determination of Nicotine
in Smoke Condensate – Gas Chromatographic Method, second ed. International
Organization for Standardization, Geneva, Switzerland.
ISO, 2007. International Standard ISO 8454, Cigarettes – Determination of Carbon
Monoxide in the Vapour Phase of Cigarette Smoke – NDIR Method, third ed.
International Organization for Standardization, Geneva, Switzerland.
LaVoie, E.J., Adams, J.D., Reinhardt, J., Rivenson, A., Hoffmann, D., 1986. Toxicity
studies on clove cigarette smoke and constituents of clove: determination of the
LD50 of eugenol by intratracheal instillation in rats and hamsters. Arch. Toxicol.
59, 78–81.
Lorge, E., Lambert, C., Gervais, V., Becourt-Lhote, N., Delongeas, J.L., Claude, N., 2007.
Genetic toxicity assessment: employing the best science for human safety
evaluation. Part II: performances of the in vitro micronucleus test compared to
the mouse lymphoma assay and the in vitro chromosome aberration assay.
Toxicol. Sci. 96, 214–217.
Maron, D.M., Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity
test. Mutat. Res. 113, 173–215.
Miller, E.C., Swanson, A.B., Phillips, D.H., Fletcher, T.L., Liem, A., Miller, J.A., 1983.
Structure-activity studies of the carcinogenicities in the mouse and rat of some
naturally occurring and synthetic alkenylbenzene derivatives related to safrole
and estragole. Cancer Res. 43, 1124–1134.
Myhr, B.C., Caspary, W.J., 1991. Chemical mutagenesis at the thymidine kinase locus
in L5178Y mouse lymphoma cells: results for 31 coded compounds in the
National Toxicology Program. Environ. Mol. Mutagen. 18, 51–83.
S80 E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S66–S80OECD, 1997a. OECD Guideline 471, Bacterial Reverse Mutation Test. Organization
for Economic Cooperation and Development, Paris, France.
OECD, 1997b. OECD Guideline 476, In Vitro Mammalian Cell Gene Mutation Test.
Organization for Economic Cooperation and Development, Paris, France.
Piadé, J.-J., Roemer, E., Dempsey, R., Hornig, G., Deger Evans, A., Völkel, H., Schramke,
H., Trelles-Sticken, E., Wittke, S., Weber, S., Schorp, M.K., 2014. Toxicological
assessment of kretek cigarettes. Part 2: kreteks and American-blend cigarettes,
smoke chemistry and in vitro toxicity. Regul. Toxicol. Pharmacol. 70, S15–S25.
Polzin, G.M., Stanﬁll, S.B., Brown, C.R., Ashley, D.L., Watson, C.H., 2007.
Determination of eugenol, anethole, and coumarin in the mainstream
cigarette smoke of Indonesian clove cigarettes. Food Chem. Toxicol. 45, 1948–
1953.
Potts, R.J., Bombick, B.R., Meckley, D.R., Ayres, P.H., Pence, D.H., 2010. A summary of
toxicological and chemical data relevant to the evaluation of cast sheet tobacco.
Exp. Toxicol. Pathol. 62, 117–126.
Purkis, S.W., Mueller, C., Intorp, M., 2011. The fate of ingredients in and impact on
cigarette smoke. Food Chem. Toxicol. 49, 3238–3248.
Reeve, L., Baldrick, P., Hewings, S., Skinner, M., 2012. A battery of genotoxicity
studies with an allergy vaccine adjuvanted with monophosphoryl lipid A
(MPL(R)) for the treatment of grass pollen allergy. J. Appl. Toxicol. 32, 608–616.
Renne, R.A., Yoshimura, H., Yoshino, K., Lulham, G., Minamisawa, S., Tribukait, A.,
Dietz, D.D., Lee, K.M., Westerberg, R.B., 2006. Effects of ﬂavoring and casing
ingredients on the toxicity of mainstream cigarette smoke in rats. Inhal. Toxicol.
18, 685–706.
Rickert, W.S., Trivedi, A.H., Momin, R.A., Wagstaff, W.G., Lauterbach, J.H., 2011.
Mutagenic, cytotoxic, and genotoxic properties of tobacco smoke produced by
cigarillos available on the Canadian market. Regul. Toxicol. Pharmacol. 61, 199–
209.
Rickert, W.S., Wright, W.G., Trivedi, A.H., Momin, R.A., Lauterbach, J.H., 2007. A
comparative study of the mutagenicity of various types of tobacco products.
Regul. Toxicol. Pharmacol. 48, 320–330.
Roemer, E., Carchman, R.A., 2011. Limitations of cigarette machine smoking
regimens. Toxicol. Lett. 203, 20–27.
Roemer, E., Dempsey, R., Lawless-Pyne, J., Lukman, S., Deger Evans, A., Trelles-
Sticken, E., Wittke, S., Schorp, M.K., 2014a. Toxicological assessment of kretek
cigarettes. Part 4: mechanistic investigations, smoke chemistry and in vitro
toxicity. Regul. Toxicol. Pharmacol. 70, S41–S53.
Roemer, E., Dempsey, R., Schorp, M.K., 2014b. Toxicological assessment of kretek
cigarettes. Part 1: background, assessment approach, and summary of ﬁndings.
Regul. Toxicol. Pharmacol. 70, S2–S14.
Roemer, E., Ottmueller, T.H., Zenzen, V., Wittke, S., Radtke, F., Blanco, I., Carchman,
R.A., 2009. Cytotoxicity, mutagenicity, and tumorigenicity of mainstream
smoke from three reference cigarettes machine-smoked to the same yields of
total particulate matter per cigarette. Food Chem. Toxicol. 47, 1810–1818.
Roemer, E., Schramke, H., Weiler, H., Buettner, A., Kausche, S., Weber, S., Berges, A.,
Stueber, M., Muench, M., Trelles-Sticken, E., Pype, J., Kohlgrueber, K., Voelkel, H.,Wittke, 2012. Mainstream smoke chemistry and in vitro and in vivo toxicity of
the reference cigarette 3R4F and 2R4F. Beitr Tabakforsch Int. 25, 316–335.
Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D.J., Meisgen, T.J., Reininghaus, W.,
Carchman, R.A., Gaworski, C.L., Podraza, K.F., 2004. Chemical composition,
cytotoxicity and mutagenicity of smoke from US commercial and reference
cigarettes smoked under two sets of machine smoking conditions. Toxicology
195, 31–52.
Roemer, E., Tewes, F.J., Meisgen, T.J., Veltel, D.J., Carmines, E.L., 2002. Evaluation of
the potential effects of ingredients added to cigarettes. Part 3: in vitro
genotoxicity and cytotoxicity. Food Chem. Toxicol. 40, 105–111.
Rustemeier, K., Stabbert, R., Haussmann, H.J., Roemer, E., Carmines, E.L., 2002.
Evaluation of the potential effects of ingredients added to cigarettes.
Part 2: chemical composition of mainstream smoke. Food Chem. Toxicol. 40,
93–104.
Schramke, H., Meisgen, T.J., Tewes, F.J., Gomm, W., Roemer, E., 2006. The mouse
lymphoma thymidine kinase assay for the assessment and comparison of the
mutagenic activity of cigarette mainstream smoke particulate phase.
Toxicology 227, 193–210.
Schramke, H., Roemer, E., Dempsey, R., Hirter, J., Meurrens, K., Berges, A., Weiler, H.,
Vanscheeuwijck, P., Schorp, M.K., 2014. Toxicological assessment of kretek
cigarettes. Part 7: the impact of ingredients added to kretek cigarettes on
inhalation toxicity. Regul. Toxicol. Pharmacol. 70, S81–S89.
Stavanja, M.S., Ayres, P.H., Meckley, D.R., Bombick, E.R., Borgerding, M.F., Morton,
M.J., Garner, C.D., Pence, D.H., Swauger, J.E., 2006. Safety assessment of high
fructose corn syrup (HFCS) as an ingredient added to cigarette tobacco. Exp.
Toxicol. Pathol. 57, 267–281.
Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J.,
Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., et al., 1987. Prediction of
chemical carcinogenicity in rodents from in vitro genetic toxicity assays.
Science 236, 933–941.
Tisserand, R., Young, R., 2014. Essential Oil Safety, second ed. Churchill Livingston
Elsevier, London.
US-CPSC, 1993. US Consumer Product Safety Commission: Toxicity Testing Plan for
Low Ignition-Potential Cigarettes. vol. 3, Washington DC.
US-DHHS, 2008. Guidance on Genotoxicity Testing and Data Evaluation for
Pharmaceuticals Intended for Human Use S2(R1). U.S. Department of Health
and Human Services, Food and Drug Administration, Silver Spring, MD, USA.
Vanscheeuwijck, P.M., Teredesai, A., Terpstra, P.M., Verbeeck, J., Kuhl, P.,
Gerstenberg, B., Gebel, S., Carmines, E.L., 2002. Evaluation of the potential
effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity.
Food Chem. Toxicol. 40, 113–131.
WHO, 2009. WHO Technical Report Series 955, WHO Study Group on Tobacco
Product Regulation, Report on the Scientiﬁc Basis of Tobacco Product
Regulation: Third Report of the WHO Study Group. World Health
Organization, Geneva, Switzerland.
